Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thimerosal and boric acid powder vs ofloxacin for otitis externa
TCTR20230316003Phase 3Completed
- Sponsor
- Department of Otolaryngology, Ramathibodi Hospital
- Start
- Aug 2021
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thimerosal, boric acid, ofloxacin in external otitis, sponsored by Department of Otolaryngology, Ramathibodi Hospital. Started Aug 2021; status: completed.
02
Drugs
thimerosalboric acidofloxacin
03
Conditions
external otitis
Beyond the preview
Go deeper on TCTR20230316003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230316003.